Saving central vision.
Not all macular degeneration is the same. Macular degeneration broadly describes the loss of cells within the macula, the central part of the retina critical for high-resolution sight. Degeneration of the macula may be linked to age, genetics, or acquired conditions.
In the clinic and operating room, we are using medications and surgery to alter the course of these blinding conditions. We have published several studies in peer-reviewed journals on the use of anti-VEGF therapy for bilateral injections, peripapillary choroidal neovascularization, macular telangiectasia, and women during pregnancy. We also identified surgeries that may delay the progression of age-related macular degeneration.
In the laboratory, we are using genetics and proteomics analysis to identify the causes and new therapeutic targets for macular degeneration. We are fortunate to have won competitive grant support and received philanthropic support for these studies.
Please contact us for a consultation or learn how to support our research programs.
Surgery for AMD
Whether vitrectomy surgery for age-related macular degeneration (AMD) is harmful or helpful is not known. A study we co-authored suggests
New Inherited Eye Disease Discovered
Researchers have found the existence of a new, rare inherited retinal disease. Now the search is on to find the
Genetics of Macular Degeneration
Genetics plays an important role in the development of age-related macular degeneration. We studied gene variations in a large group
AMD near the optic nerve
Sometimes abnormal blood vessels grow near the optic nerve rather than underneath the fovea. The best way to treat these
Treating Macular Telangiectasis
Idiopathic macular telangiectasia is a condition where abnormal blood vessels are associated with central vision loss. We published a study